Showing results (291-300 of 855) with videos related to
Sort By:
Pageof 86
Kidney International|July 24, 2009
V1/V2 Vasopressin receptor antagonism potentiates the renoprotection of renin-angiotensin system inhibition in rats with renal mass reductionNorberto Perico, Carla Zoja, Daniela Corna, et al.Ebiomedicine|November 1, 2020
COVID-19 and lombardy: TESTing the impact of the first wave of the pandemicLuca Perico, Susanna Tomasoni, Tobia Peracchi, et al.American Journal of Physiology. Renal Physiology|August 20, 2010
Adding a statin to a combination of ACE inhibitor and ARB normalizes proteinuria in experimental diabetes, which translates into full renoprotectionCarla Zoja, Daniela Corna, Elena Gagliardini, et al.Frontiers in Pharmacology|October 28, 2022
Drugs for the prevention and treatment of COVID-19 and its complications: An update on what we learned in the past 2 yearsGiuseppe Remuzzi, Stefano Schiaffino, Maria Gabriella Santoro, et al.Clinical Journal of the American Society of Nephrology : CJASN|October 12, 2007
Pharmacokinetics of mycophenolate sodium and comparison with the mofetil formulation in stable kidney transplant recipientsDario Cattaneo, Monica Cortinovis, Sara Baldelli, et al.Journal of the American Society of Nephrology : JASN|June 24, 2003
Rituximab in idiopathic membranous nephropathy: a one-year prospective studyPiero Ruggenenti, Carlos Chiurchiu, Varusca Brusegan, et al.Nature Reviews. Nephrology|October 20, 2020
Immunity, endothelial injury and complement-induced coagulopathy in COVID-19Luca Perico, Ariela Benigni, Federica Casiraghi, et al.Biomaterials|May 10, 2005
Subcutaneous xenotransplantation of bovine pancreatic isletsMarina Figliuzzi, Roberta Cornolti, Tiziana Plati, et al.Nephron. Clinical Practice|June 9, 2005
Cyclosporine prolongs delayed graft function in kidney transplantation: are rabbit anti-human thymocyte globulins the answer?Paolo Cravedi, Igor Codreanu, Antonio Satta, et al.Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Rituximab for idiopathic membranous nephropathy: who can benefit?Piero Ruggenenti, Carlos Chiurchiu, Mauro Abbate, et al.Pageof 86